I am a postdoctoral researcher working on the interface of computational biology, machine learning and oncology in the MLCB lab of Prof. K. Borgwardt at ETH Zurich. My expertise in both, practical biological lab work and computational implementations sets me apart from other computational biologists. This experience and my motivation to further scientific progress enable me to pursue challenging projects where multidisciplinary work is key.
My current projects span a range of topics including the prediction of Alzheimer’s disease using deep convolutional neural networks, the modelling of the Sars-CoV-2 epidemic in the city of Basel, and the simultion of intermittent treatments for recurrent high grade glioma patients.
Before joining ETH Zurich I completed my Phd at the Institute of Cancer Reseach under the supervision of Prof. Gail terHaar and Prof. Uwe Oelfke on the topic of analysis and simulation of combination treatments of radiation and focused ultrasound mediated heating.
For a complete and up-to-date list of my publications, please check out my Google Scholar profile.
This is the main topic of my current Postdoc where I am investigating deep convolutional neural networks for the identification of imaging biomarkers of Alzheimer’s Disease. Check out our preprint on arXiv. This work was also be presented at this year’s Neurips ML4H workshop and Medical Imaging Meets Neurips workshop.
This collaboration with the Unispital Basel aims to analyse the spatio-temporal spread of the Sars-CoV2 epidemic in the city of Basel to use the obtained information to guide vaccination scenarios. We base our simulations on a SEIR-model together with dynamic information on within city mobility, social interactions, and the socioeconomic structure of the city. This work has now been submitted for publication and now published on medrXive.
This project is a collaboration with Dr. Heiko Enderling and Jeff Peakock, MD at the Moffitt Cancer center, Tampa, FL. We started this project at the 2019 IMO workshop and are investigating intermittent radiotherapy as an alternative, palliative treatment to hypofractionated stereotactic radio surgery for recurrent high grade glioma patients. This work was presented at SMB in August 2020. Stay tuned for our publication which is in the late stages of preparation.
This is work I performed during my PhD - have a look at the publications resulting from it: I designed an experimental set-up to perform in vitro focused ultrasound experiments, developped a cell survivial model quantifying the biological effects of radition and hyperthermia, studied the reponse of 3D tumour spheroids to these combination treatments, and also implemented a cellular automaton framework simulating the dynamic response of 2D and 3D cell cultures under radition and hyperthermia treatments.